<?xml version="1.0" encoding="UTF-8"?>
<p>Functional dyspepsia (FD), a common gastroduodenal disorder, is defined by individual symptoms. Symptoms of functional dyspepsia such as postprandial fullness, early satiety, epigastric burning, or epigastric pain are often related to meal, but not to the abdominal pain, and affect one in five people in the community [
 <xref rid="B1" ref-type="bibr">1</xref>–
 <xref rid="B3" ref-type="bibr">3</xref>]. Effective therapies for functional dyspepsia are limited although acid secretion inhibitors, H2 blockers, proton pump inhibitors, prokinetics, 
 <italic>H. pylori</italic> eradication treatment, antidepressants, psychotherapy, and mirtazapine may provide some symptom relief in clinical practice [
 <xref rid="B1" ref-type="bibr">1</xref>–
 <xref rid="B4" ref-type="bibr">4</xref>]. As there is no satisfactory medication for the treatment of FD, and the control of symptoms is a more realistic end point, more effective therapies should be presented as the main goal of treatment to achieve fewer adverse effects than conventional medications [
 <xref rid="B2" ref-type="bibr">2</xref>, 
 <xref rid="B4" ref-type="bibr">4</xref>]. Traditional medicines in treating functional gastrointestinal disorders are valuable sources for new drug discovery [
 <xref rid="B2" ref-type="bibr">2</xref>].
</p>
